Know Cancer

or
forgot password
  • cancer clinical trials in charlottesville, VA

  • Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Breast Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Brain and Central Nervous System Tumors
    Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Endometrial Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Sarcoma
    Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Sarcoma
    Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Cervical Cancer
    Combination Chemotherapy in Treating Children With Neuroblastoma
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Neuroblastoma
    Surgery in Treating Children With Neuroblastoma
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Neuroblastoma
    Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Sarcoma
    Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Breast Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Leukemia
    Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Endometrial Cancer
    Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Melanoma (Skin)
    Vinorelbine in Treating Children With Recurrent or Refractory Cancers
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma
    Brachytherapy in Treating Patients With Prostate Cancer
    Cancer Center, University of Virginia HSC

    Trial Locations
    Cancer Center, University of Virginia HSC
    Martha Jefferson Hospital
    Prostate Cancer
    Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Ovarian Cancer
    Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Brain and Central Nervous System Tumors
    Docetaxel in Treating Patients With Solid Tumors
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Bladder Cancer, Breast Cancer, Head and Neck Cancer, Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Lung Cancer
    Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
    Cancer Center, University of Virginia HSC

    Trial Locations
    Cancer Center, University of Virginia HSC
    Martha Jefferson Hospital
    Pancreatic Cancer
    Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Endometrial Cancer
    Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Sarcoma
    Bexarotene in Treating Patients With Metastatic Breast Cancer
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Breast Cancer
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Leukemia
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    Cancer Center, University of Virginia HSC

    Trial Locations
    Cancer Center, University of Virginia HSC
    Martha Jefferson Hospital
    Diarrhea, Radiation Enteritis
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Breast Cancer
    Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Cardiac Toxicity, Sarcoma
    Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Endometrial Cancer
    S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Lung Cancer
    Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
    University of Virginia
    Charlottesville, Virginia 22908
    Hemolytic Uremic Syndrome
    Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
    University of Virginia Cancer Center at UV Health System
    Charlottesville, Virginia 22908
    Lung Cancer
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Anemia, Head and Neck Cancer
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Endometrial Cancer
    Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Head and Neck Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    Cancer Center, University of Virginia HSC

    Trial Locations
    Cancer Center, University of Virginia HSC
    Martha Jefferson Hospital
    Head and Neck Cancer
    Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
    University of Virginia Cancer Center
    Charlottesville, Virginia 22908
    Leukemia
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Leukemia
    Chemotherapy in Treating Patients With Sarcoma of the Uterus
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Endometrial Cancer, Sarcoma
    Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer
    Cancer Center, University of Virginia HSC
    Charlottesville, Virginia 22908
    Cervical Cancer
    Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Anxiety Disorder, Depression, Fatigue, Lung Cancer
    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Leukemia, Lymphoma
    Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Endometrial Cancer
    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Lymphoma
    Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Cervical Cancer
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    Cancer Center at the University of Virginia

    Trial Locations
    Cancer Center at the University of Virginia
    Martha Jefferson Hospital
    Prostate Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Cancer Center at the University of Virginia

    Trial Locations
    Cancer Center at the University of Virginia
    Martha Jefferson Hospital
    Brain and Central Nervous System Tumors
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Martha Jefferson Hospital
    Charlottesville, Virginia 22901
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Cervical Cancer
    Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
    Cancer Center at the University of Virginia
    Charlottesville, Virginia 22908
    Sarcoma